Newsroom
Sorted by: Latest
-
Sensorion annonce sa participation à la conférence Annuelle de la Société Américaine de Thérapie Génique et Cellulaire (ASGCT)
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et prévenir les troubles de la perte auditive, annonce aujourd'hui sa participation à la 29ème conférence de la Société Américaine de Thérapie Génique et Cellulaire (ASGCT), qui se tiendra du 11 au 15 mai 2026, à Boston, aux États-Unis d’Amérique. Laurent Desire, Head of Pr...
-
Sensorion Announces its Participation in the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss disorders, today announces its participation in the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, taking place on May 11-15, 2026, in Boston, United-States. Laurent Desire, Head of Preclinical Development at Sensorion, will present the followi...
-
BW LPG Limited – Notice of Annual General Meeting 2026
SINGAPORE--(BUSINESS WIRE)--Notice is hereby given that the 2026 Annual General Meeting of BW LPG Limited will be conducted as per the details below: Date: Thursday, 28 May 2026 Location: 10 Pasir Panjang Road, Mapletree Business City #18-01, Singapore 117438 Time: 11:30am local time Please see attached documents for the Notice of Annual General Meeting, Form of Proxy and Recommendation from the Nomination Committee. About BW LPG BW LPG is the world’s leading owner and operator of LPG vessels,...
-
AB InBev Reports First Quarter 2026 Results
BRUSSELS--(BUSINESS WIRE)--Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): Regulated information1 “Cheers to beer - the strength of the category and the consistent execution of our consumer-centric strategy drove continued momentum across our footprint. We are investing behind our megabrands and innovations to lead and grow the category. With strong execution by our teams and major moments of celebration ahead, we are well positioned for 2026.” – Michel Doukeris, CEO, AB InBe...
-
AB InBev publiceert de resultaten voor het eerste kwartaal van 2026
BRUSSEL--(BUSINESS WIRE)--Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): Gereglementeerde informatie1 “Proost op bier - de kracht van de categorie en de consistente uitvoering van onze consumentgerichte strategie zorgden voor aanhoudend momentum in alle markten waar we aanwezig zijn. We zijn aan het investeren in onze megamerken en innovaties om de categorie te leiden en te doen groeien. Met een sterke uitvoering door onze teams en belangrijke momenten om te vieren in het ve...
-
AB InBev publie les résultats du premier trimestre 2026
BRUXELLES--(BUSINESS WIRE)--Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): Information réglementée1 « Célébrons la bière – la force de la catégorie et l’exécution régulière de notre stratégie centrée sur le consommateur ont assuré le maintien de la dynamique à travers notre empreinte. Nous investissons dans nos méga-marques et nos innovations pour mener et développer la catégorie. Avec une exécution solide de la part de nos équipes et des moments majeurs de célébrations à ve...
-
Amrize Launches $1 Billion Share Buyback Program
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) will start its previously announced share buyback program on May 6, 2026. The program has been authorized for a total of $1 billion USD until May 5, 2027, with the shares to be repurchased for the purpose of cancellation. The share buyback program will be executed on a second trading line on SIX Swiss Stock Exchange (Valor: 156 026 729 , ISIN: CH 156 026 729 1 and Ticker: AMRZE). Concurrently with this press release, Amrize has publishe...
-
CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time
ROSARIO, Argentina--(BUSINESS WIRE)--The dial-in details of release dated May 4, 2026 have been revised. The US Toll Free dial-in number should read 1-833-461-5787; the International dial-in numbers link has been updated; and the Conference ID: should read 717574163. The updated release reads: BIOCERES CROP SOLUTIONS TO HOST FISCAL THIRD QUARTER 2026 FINANCIAL RESULTS CONFERENCE CALL ON TUESDAY, MAY 12, 2026 AT 8:30 A.M. EASTERN TIME Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or t...
-
Anomali Launches ThreatStream Next-Gen to Turn Intelligence Into Action — at the Speed Threats Demand
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Somewhere right now, a security analyst is triaging alerts at two in the morning — not because there are more threats, but because there is no system helping them decide which ones matter. Anomali, whose intelligence solution has been trusted by global enterprises and government organizations for over a decade, today announced Anomali ThreatStream Next-Gen to change that. Available both as a standalone intelligence solution and embedded within the Anomali...
-
ProPetro Holding Corp. Prices Upsized $600 Million Convertible Senior Notes Offering
MIDLAND, Texas--(BUSINESS WIRE)--ProPetro Holding Corp. Prices Upsized $600 Million Convertible Senior Notes Offering...